FINWIRES · TerminalLIVE
FINWIRES

EMEA Oil Update: Futures Ease From Record Highs as Middle East Conflict Intensifies

作者

-- Oil futures eased on Thursday with Brent breaching $126 per barrel mark earlier in the session as traders braced for a prolonged supply deficit fueled by the US-Iran war.

Front-month Murban crude futures slipped by 3.4% to $109.61 per barrel, while Brent futures fell 3.3% to $114.11/bbl and hit a high of $126 earlier in the session.

"Brent cracks 120/bbl as supply shortages mount," ANZ analysts said.

"The rally in crude oil prices shows no signs of slowing, as the prospect of an indefinite closure of the Strait of Hormuz weighs on sentiment," ANZ added.

The breakdown in diplomacy, paired with a directive from President Trump to prepare for an extended blockade, has left traders bracing for a protracted supply deficit that demand destruction alone may not be able to bridge.

"The breakdown of talks between the US and Iran, along with President Trump reportedly rejecting Iran's proposal for a reopening of the Strait of Hormuz, has the market losing hope for any quick resumption in oil flows," ING said.

"While we estimate demand destruction in the region of 1.6m b/d, which is significant, it's clearly not enough to fill the supply gap we are currently facing," ING added.

The market's ability to rely on existing stockpiles is rapidly eroding.

Data from analytics firm Kpler indicates that Iran has only 12 to 22 days of unused storage capacity remaining.

Once these facilities are full, Tehran will be forced to cut daily output by an additional 1.5 million to 1.6 million barrels per day.

This looming cut would be layered on top of the estimated 10 mb/d already shut in due to the strait's closure.

ING analysts warned that while regional demand destruction is estimated at roughly 1.6 mb/d, it remains insufficient to fill the widening supply gap, suggesting that significantly higher prices may be the only remaining lever to balance the market.

US crude stockpiles dropped by 6.2 million barrels to 459.5 mmbbls in the week ended April 24, the Energy Information Administration said in its weekly report on Wednesday, amid signs of tightening supplies.

Meanwhile, Trump on Wednesday reportedly said the UAE's decision to leave OPEC could help ease rising energy prices.

相关文章

Sectors

行业动态:消费者

周四下午,消费类股票走高,道富消费必需品精选行业SPDR ETF (XLP)上涨1.4%,道富非必需消费品精选行业SPDR ETF (XLY)上涨0.4%。 公司方面,兰姆韦斯顿(LW)股价上涨1.6%,此前股东Starboard Value周四致信董事会,表示公司应召开投资者日活动,并将盈利预期调整至正常水平。

$LW
Research

研究快讯:CFRA维持对Firstenergy Corp.股票的买入评级。

独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下:我们将12个月目标股价下调1美元至55美元,市盈率为20倍,基于未来12个月每股收益预期2.75美元,高于五年平均水平15.6倍。我们将2026年每股收益预期下调0.02美元至2.72美元,并将2027年每股收益预期下调0.01美元至2.93美元。第一季度核心每股收益同比增长7.5%,打破了此前连续三个季度下滑的局面,我们预计在整个预测期内,增长势头将持续。 我们观察到数据中心需求呈现积极趋势,长期合同需求(4.3 GW)自 2026 年 2 月(4.1 GW)以来增长了 4%,自 2025 年 2 月(2.9 GW)以来增长了 47%;同时,在建项目需求(14.9 GW)自 2026 年 2 月(12.9 GW)以来增长了 15%,自 2025 年 2 月(6.1 GW)以来增长了一倍以上。自 2022 年以来,FE 已将基础运维成本降低了 2 亿美元以上(15%),预计 2026 年第一季度将同比进一步下降约 5%,同时可靠性指标也得到提升。我们认为,FE 的成本控制、服务质量的提升以及具有竞争力的价格定位,将转化为更有利的费率调整结果、更低的拒付风险以及更高的潜在净资产收益率 (ROE)。

$FE
Australia

市场动态:FDA专家组投票反对阿斯利康乳腺癌药物的益处

据彭博社周四报道,美国食品药品监督管理局(FDA)肿瘤药物咨询委员会否决了阿斯利康(AZN)用于治疗乳腺癌的候选药物卡美司群(Camizestrant)的疗效。 彭博社称,六名委员会成员投票反对该药物,原因是他们对试验设计及其在临床应用中的潜在影响存在分歧。 根据一份简报文件,该药物试验达到了无进展生存期(PFS)的主要终点以及无进展生存期2(PFS2)终点,但FDA认为PFS2不适合作为监管决策的终点。 (市场动态新闻来源于与全球市场专业人士的对话。这些信息据信来自可靠来源,但可能包含传闻和推测。准确性无法保证。)Price: $189.60, Change: $+4.40, Percent Change: +2.37%

$AZN